These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2106358

  • 1. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease.
    Uebelhart D, Gineyts E, Chapuy MC, Delmas PD.
    Bone Miner; 1990 Jan; 8(1):87-96. PubMed ID: 2106358
    [Abstract] [Full Text] [Related]

  • 2. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover.
    Beardsworth LJ, Eyre DR, Dickson IR.
    J Bone Miner Res; 1990 Jul; 5(7):671-6. PubMed ID: 2118710
    [Abstract] [Full Text] [Related]

  • 3. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P, Gineyts E, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [Abstract] [Full Text] [Related]

  • 4. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
    Simsek B, Karacaer O, Karaca I.
    Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
    Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ.
    Eur J Clin Invest; 1991 Jun; 21(3):310-5. PubMed ID: 1909635
    [Abstract] [Full Text] [Related]

  • 6. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
    Gorai I, Taguchi Y, Chaki O, Nakayama M, Minaguchi H.
    Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
    [Abstract] [Full Text] [Related]

  • 7. High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption.
    Kamel S, Brazier M, Desmet G, Picard C, Mennecier I, Sebert J.
    J Chromatogr; 1992 Feb 14; 574(2):255-60. PubMed ID: 1618957
    [Abstract] [Full Text] [Related]

  • 8. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP).
    Açil Y, Brinckmann J, Notbohm H, Müller PK, Bätge B.
    Scand J Clin Lab Invest; 1996 May 14; 56(3):275-83. PubMed ID: 8761532
    [Abstract] [Full Text] [Related]

  • 9. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M, Stepan JJ, Wilczek H, Formankova J, Moro L.
    Clin Chim Acta; 1995 Jan 31; 234(1-2):101-8. PubMed ID: 7758208
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone.
    Sinigaglia L, Varenna M, Binelli L, Beltrametti P, Zucchi F, Arrigoni M, Frignani S, Abbiati G.
    Calcif Tissue Int; 1997 Oct 31; 61(4):279-84. PubMed ID: 9312197
    [Abstract] [Full Text] [Related]

  • 11. Urinary excretion of pyridinium crosslinks of collagen in oophorectomized women as markers for bone resorption.
    Hashimoto K, Nozaki M, Yokoyama M, Sano M, Nakano H.
    Maturitas; 1994 Feb 31; 18(2):135-42. PubMed ID: 8177094
    [Abstract] [Full Text] [Related]

  • 12. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
    Bettica P, Moro L, Robins SP, Taylor AK, Talbot J, Singer FR, Baylink DJ.
    Clin Chem; 1992 Nov 31; 38(11):2313-8. PubMed ID: 1424129
    [Abstract] [Full Text] [Related]

  • 13. Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.
    Adami S, Zamberlan N, Mian M, Dorizzi R, Rossini M, Braga B, Gatti D, Bertoldo F, Locascio V.
    Bone Miner; 1994 May 31; 25(2):75-82. PubMed ID: 8086853
    [Abstract] [Full Text] [Related]

  • 14. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S, Brazier M, Rogez JC, Vincent O, Maamer M, Desmet G, Sebert JL.
    J Clin Endocrinol Metab; 1996 Oct 31; 81(10):3717-21. PubMed ID: 8855828
    [Abstract] [Full Text] [Related]

  • 15. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
    Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ.
    J Bone Miner Res; 1994 Oct 31; 9(10):1643-9. PubMed ID: 7817812
    [Abstract] [Full Text] [Related]

  • 16. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
    Hamdy NA, Papapoulos SE, Colwell A, Eastell R, Russell RG.
    Bone Miner; 1993 Jul 31; 22(1):1-8. PubMed ID: 8219934
    [Abstract] [Full Text] [Related]

  • 17. Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism.
    LoCascio V, Braga V, Bertoldo F, Bettica P, Pasini AF, Stefani L, Moro L.
    Clin Endocrinol (Oxf); 1994 Jul 31; 41(1):47-51. PubMed ID: 8050131
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion level of hydroxylysylpyridinoline as an index of bone resorption.
    Yoshihara K, Nemoto S, Nagata M.
    Biol Pharm Bull; 1994 Jun 31; 17(6):840-2. PubMed ID: 7951150
    [Abstract] [Full Text] [Related]

  • 19. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
    Krane SM, Kantrowitz FG, Byrne M, Pinnell SR, Singer FR.
    J Clin Invest; 1977 May 31; 59(5):819-27. PubMed ID: 404321
    [Abstract] [Full Text] [Related]

  • 20. Rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline.
    Açil Y, Müller PK.
    J Chromatogr A; 1994 Apr 01; 664(2):183-8. PubMed ID: 21941695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.